207 related articles for article (PubMed ID: 19273690)
21. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved?
Hunt P; Cravo PV; Donleavy P; Carlton JM; Walliker D
Mol Biochem Parasitol; 2004 Jan; 133(1):27-35. PubMed ID: 14668009
[TBL] [Abstract][Full Text] [Related]
23. Fitness of drug-resistant malaria parasites.
Walliker D; Hunt P; Babiker H
Acta Trop; 2005 Jun; 94(3):251-9. PubMed ID: 15845348
[TBL] [Abstract][Full Text] [Related]
24. Resistance to chloroquine therapy in pregnant women with malaria parasitemia.
Rukaria-Kaumbutho RM; Ojwang SB; Oyieke JB
Int J Gynaecol Obstet; 1996 Jun; 53(3):235-41. PubMed ID: 8793625
[TBL] [Abstract][Full Text] [Related]
25. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
[TBL] [Abstract][Full Text] [Related]
26. Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar.
Ariey F; Randrianarivelojosia M; Duchemin JB; Rakotondramarina D; Ouledi A; Robert V; Jambou R; Jahevitra M; Andrianantenaina H; Raharimalala L; Mauclère P
J Infect Dis; 2002 Mar; 185(5):710-2. PubMed ID: 11865433
[No Abstract] [Full Text] [Related]
27. Gene synteny and chloroquine resistance in Plasmodium chabaudi.
Hunt P; Martinelli A; Fawcett R; Carlton J; Carter R; Walliker D
Mol Biochem Parasitol; 2004 Aug; 136(2):157-64. PubMed ID: 15478795
[TBL] [Abstract][Full Text] [Related]
28. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
29. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia.
Fryauff DJ; Baird JK; Candradikusuma D; Masbar S; Sutamihardja MA; Leksana B; Tuti S; Marwoto H; Richie T; Romzan A
Am J Trop Med Hyg; 1997 Feb; 56(2):241-4. PubMed ID: 9080887
[TBL] [Abstract][Full Text] [Related]
30. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
[TBL] [Abstract][Full Text] [Related]
32. Quinine sensitivity of isolates of Plasmodium falciparum from the coast of Kenya.
Haruki K; Winstanley PA; Watkins WM; Marsh K
Trans R Soc Trop Med Hyg; 1998; 92(2):195-6. PubMed ID: 9764332
[No Abstract] [Full Text] [Related]
33. Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
Schwenke A; Brandts C; Philipps J; Winkler S; Wernsdorfer WH; Kremsner PG
Wien Klin Wochenschr; 2001 Jan; 113(1-2):63-4. PubMed ID: 11233471
[TBL] [Abstract][Full Text] [Related]
34. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro.
Balmer P; Phillips HM; Maestre AE; McMonagle FA; Phillips RS
Parasite Immunol; 2000 Feb; 22(2):97-106. PubMed ID: 10652122
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo properties of ellagic acid in malaria treatment.
Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
[TBL] [Abstract][Full Text] [Related]
37. Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice.
Pouvelle B; Farley PJ; Long CA; Taraschi TF
J Clin Invest; 1994 Jul; 94(1):413-7. PubMed ID: 7913713
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antimalarial activities of T-2307, a novel arylamidine.
Kimura A; Nishikawa H; Nomura N; Mitsuyama J; Fukumoto S; Inoue N; Kawazu S
Antimicrob Agents Chemother; 2012 Apr; 56(4):2191-3. PubMed ID: 22252809
[TBL] [Abstract][Full Text] [Related]
39. Variation of incubation time in an in vitro drug susceptibility test of Plasmodium falciparum isolates studied in the Solomon Islands.
Inaba H; Ohmae H; Kano S; Faarado L; Boaz L; Leafasia J; Suzuki M
Parasitol Int; 2001 Mar; 50(1):9-13. PubMed ID: 11267927
[TBL] [Abstract][Full Text] [Related]
40. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique.
Hogh B; Thompson R; Hetzel C; Fleck SL; Kruse NA; Jones I; Dgedge M; Barreto J; Sinden RE
Am J Trop Med Hyg; 1995 Jan; 52(1):50-9. PubMed ID: 7856825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
